Gritstone Oncology

by | Jul 13, 2016 | Current Participants

Gritstone Oncology Every patient’s tumor is molecularly unique – Gritstone Oncology deploys a proprietary tumor antigen prediction model based upon patient tumor sequencing/mass spectrometry to deliver antigens as personalized therapeutic vaccine alongside...

CloudmedX

by | Jul 13, 2016 | Current Participants

CloudMedx CloudMedx is a health technology company that focuses on streamlining clinical encounters and optimizing patient and financial outcomes through predictive analytics. The company utilizes evidence based algorithms, machine learning and natural language...

Cernostics

by | Jul 13, 2016 | Current Participants

Cernostics Cernostics is focused on delivering next generation cancer diagnostics and prognostics through an innovative approach to tissue analysis – the evaluation of the tumor as a system composed of multiple interacting cell types, including tumor, immune, and...

Accelerated Medical Diagnostics

by | Jul 13, 2016 | Current Participants

Accelerated Medical Diagnostics, Inc. Accelerated Medical Diagnostics, Inc. As a pioneer in the field of predictive chemotherapy diagnostics, the company is committed to developing clinically validated tests that empower clinicians to better tailor care to each...

AccuraGen

by | Jul 13, 2016 | Current Participants

AccuraGen Taking advantage of our proprietary technology, AccuraGen provides an ultra-accurate, and sensitive noninvasive-liquid biopsy assay that detects cancer mutations from a single vial of blood. Website:...

Get Exclusive Access to the Top PMWC Talks

To receive the most comprehensive news and updates from the field of precision medicine, subscribe to the newsletter here.

Bonus for suscribing, you will get the access code for the top 3 talk videos from January's Precision Medicine World Conference.

You have successfully subscribed, you can access the talks here.

We hate spam too, unsubscribe at any time.

Do not alert me again.